Medical Care

Global Prostate Cancer Diagnostics Market Research Report 2026

This report delivers a comprehensive overview of the global Prostate Cancer Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate Cancer Diagnostics. The Prostate Cancer Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Prostate Cancer Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Prostate Cancer Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Segment by Type
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Prostate Cancer Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2021–2032)
2.2 Global Prostate Cancer Diagnostics Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Prostate Cancer Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Prostate Cancer Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Prostate Cancer Diagnostics Market Dynamics
2.3.1 Prostate Cancer Diagnostics Industry Trends
2.3.2 Prostate Cancer Diagnostics Market Drivers
2.3.3 Prostate Cancer Diagnostics Market Challenges
2.3.4 Prostate Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Prostate Cancer Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Diagnostics Revenue
3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2025
3.5 Global Key Players of Prostate Cancer Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Prostate Cancer Diagnostics, Products and Applications
3.7 Global Key Players of Prostate Cancer Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2027–2032)
5 Prostate Cancer Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Prostate Cancer Diagnostics Market Size (2021–2032)
6.2 North America Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Prostate Cancer Diagnostics Market Size by Country (2021–2026)
6.4 North America Prostate Cancer Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics Market Size (2021–2032)
7.2 Europe Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Prostate Cancer Diagnostics Market Size by Country (2021–2026)
7.4 Europe Prostate Cancer Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Prostate Cancer Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Market Size (2021–2032)
9.2 Latin America Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Prostate Cancer Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Prostate Cancer Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OPKO
11.1.1 OPKO Company Details
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Details
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Details
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Details
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Details
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2021–2026)
11.11.5 Ambry Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Prostate Cancer Diagnostics Market Share by Region (2021–2026)
Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Prostate Cancer Diagnostics Market Share by Region (2027–2032)
Table 12. Prostate Cancer Diagnostics Market Trends
Table 13. Prostate Cancer Diagnostics Market Drivers
Table 14. Prostate Cancer Diagnostics Market Challenges
Table 15. Prostate Cancer Diagnostics Market Restraints
Table 16. Global Prostate Cancer Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Prostate Cancer Diagnostics Market Share by Players (2021–2026)
Table 18. Global Top Prostate Cancer Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Prostate Cancer Diagnostics Revenue, 2025
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Prostate Cancer Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Prostate Cancer Diagnostics, Products and Applications
Table 23. Global Key Players of Prostate Cancer Diagnostics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2021–2026)
Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2027–2032)
Table 29. Global Prostate Cancer Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2021–2026)
Table 31. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2027–2032)
Table 33. North America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 48. OPKO Company Details
Table 49. OPKO Business Overview
Table 50. OPKO Prostate Cancer Diagnostics Product
Table 51. OPKO Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 52. OPKO Recent Development
Table 53. Genomic Health Company Details
Table 54. Genomic Health Business Overview
Table 55. Genomic Health Prostate Cancer Diagnostics Product
Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 57. Genomic Health Recent Development
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Prostate Cancer Diagnostics Product
Table 61. Abbott Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 62. Abbott Recent Development
Table 63. Beckman Coulter Company Details
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product
Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 67. Beckman Coulter Recent Development
Table 68. Siemens Healthcare Company Details
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 72. Siemens Healthcare Recent Development
Table 73. bioMeriux Company Details
Table 74. bioMeriux Business Overview
Table 75. bioMeriux Prostate Cancer Diagnostics Product
Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 77. bioMeriux Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Prostate Cancer Diagnostics Product
Table 81. Roche Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 82. Roche Recent Development
Table 83. MDx Health Company Details
Table 84. MDx Health Business Overview
Table 85. MDx Health Prostate Cancer Diagnostics Product
Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 87. MDx Health Recent Development
Table 88. DiaSorin Company Details
Table 89. DiaSorin Business Overview
Table 90. DiaSorin Prostate Cancer Diagnostics Product
Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 92. DiaSorin Recent Development
Table 93. Myriad Genetics Company Details
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Prostate Cancer Diagnostics Product
Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Company Details
Table 99. Ambry Genetics Business Overview
Table 100. Ambry Genetics Prostate Cancer Diagnostics Product
Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026
Table 102. Ambry Genetics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report


List of Figures
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Prostate Cancer Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Prostate Cancer Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Tumor Biomarker Tests Features
Figure 5. Imaging Features
Figure 6. Biopsy Features
Figure 7. Other Features
Figure 8. Global Prostate Cancer Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Prostate Cancer Diagnostics Market Share by Application: 2025 vs 2032
Figure 10. Age Below 55 Case Studies
Figure 11. Age 55-75 Case Studies
Figure 12. Age Above 75 Case Studies
Figure 13. Prostate Cancer Diagnostics Report Years Considered
Figure 14. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Prostate Cancer Diagnostics Market Share by Region: 2025 vs 2032
Figure 17. Global Prostate Cancer Diagnostics Market Share by Players in 2025
Figure 18. Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2025
Figure 20. North America Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Prostate Cancer Diagnostics Market Share by Country (2021–2032)
Figure 22. United States Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Prostate Cancer Diagnostics Market Share by Country (2021–2032)
Figure 26. Germany Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Prostate Cancer Diagnostics Market Share by Region (2021–2032)
Figure 34. China Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Prostate Cancer Diagnostics Market Share by Country (2021–2032)
Figure 42. Mexico Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2021–2032)
Figure 46. Israel Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 50. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 51. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 52. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 53. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 54. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 55. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 56. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 57. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 58. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 59. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies